Australia’s Health Technology Assessment (HTA) system has served us well, but the time has come for meaningful reform.

Australia is well placed to take on a greater leadership role in pharmacovigilance (PV) across the Asia-Pacific (APAC) region.

The National One Stop Shop (NOSS) for clinical trials — transforming the country’s research operating environment.

How artificial intelligence is reshaping how the sector views ethics, inclusivity, governance, and value.

Australia’s regulatory environment for implantable medical devices is changing rapidly.

Regulatory frameworks in Australia and New Zealand share a common goal.

Generative Artificial Intelligence (GenAI) is poised to reshape the landscape of medical writing and medical information dissemination.

For those taking their first steps into the industry, the journey can feel a bit like hopping onto a treadmill that’s already going at full speed

Improvements in the efficiency and affordability of artificial intelligence (AI) and cloud-based computing have created an abundance of tools, software, and services for the recruitment industry

Delivering equitable access to clinical trials across Australia isn’t just a technical or logistical challenge—it’s a moral imperative

As Australia accelerates its journey toward net zero, the healthcare sector is becoming an important focus in the national emissions reduction strategy.

Are the full societal value of vaccines recognised in current HTA practice?